Based on data from the past 90 days ending January 09, 2026, Prelude Therapeutics's three largest insider shareholders are Director Advisors Llc Orbimed (10.12Mn shares), Director David P Bonita (10.12Mn shares), Ceo Krishna Vaddi (2.14Mn shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Advisors Llc Orbimed | 10,119,756 | 24 May, 2023 | |
| David P Bonita | 10,119,756 | 24 May, 2023 | |
| Krishna Vaddi | Ceo | 2,141,849 | 27 Mar, 2025 |
| Andrew Combs | Chief Chemistry Officer | 480,123 | 27 Mar, 2025 |
| Peggy Scherle | Chief Scientific Officer | 172,920 | 30 Aug, 2021 |
| Jane Huang | President And Cmo | 86,917 | 07 Oct, 2025 |
| Laurent Chardonnet | Chief Financial Officer | 42,165 | 25 May, 2023 |
| Bryant David Lim | Clo And Interim Cfo And Corp Sec. | 27,400 | 20 Dec, 2024 |
| Christopher Pierce | Evp And Chief Of Business Oper | 3,750 | 07 Sep, 2021 |
| Deborah Morosini | Evp And Chief Of Clinical Affairs | 444 | 17 Dec, 2021 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 04 Oct, 2025 | Jane Huang | Common Stock | A | 9,375 | - | 90,272 | D | M |
| 04 Oct, 2025 | Jane Huang | Common Stock | D | 3,355 | $1.47 | 86,917 | D | F |
| 04 Jul, 2025 | Jane Huang | Common Stock | D | 3,355 | $0.79 | 80,897 | D | F |
| 04 Jul, 2025 | Jane Huang | Common Stock | A | 9,375 | - | 84,252 | D | M |
| 04 Apr, 2025 | Jane Huang | Common Stock | D | 3,355 | $0.68 | 74,877 | D | F |
| 04 Apr, 2025 | Jane Huang | Common Stock | A | 9,375 | - | 78,232 | D | M |
| 25 Mar, 2025 | Krishna Vaddi | Common Stock | A | 675,000 | $0.69 | 1,999,296 | D | P |
| 25 Mar, 2025 | Andrew Combs | - | - | 480,123 | D | |||
| 25 Mar, 2025 | Andrew Combs | Common Stock | A | 100,000 | $0.69 | 480,123 | D | P |
| 21 Mar, 2025 | Krishna Vaddi | Common Stock | A | 15,000 | $0.73 | 1,324,296 | D | P |
| 20 Mar, 2025 | Krishna Vaddi | Common Stock | A | 5,416 | $0.73 | 1,309,296 | D | P |
| 17 Mar, 2025 | Krishna Vaddi | Common Stock | A | 9,106 | $0.75 | 1,303,880 | D | P |
| 14 Mar, 2025 | Krishna Vaddi | Common Stock | A | 29,999 | $0.75 | 1,294,774 | D | P |
| 13 Mar, 2025 | Krishna Vaddi | Common Stock | A | 50,000 | $0.72 | 1,264,775 | D | P |
| 13 Mar, 2025 | Krishna Vaddi | - | - | 1,264,775 | D | |||
| 12 Mar, 2025 | Krishna Vaddi | Common Stock | A | 47,500 | $0.71 | 1,214,775 | D | P |
| 12 Mar, 2025 | Krishna Vaddi | - | - | 1,214,775 | D | |||
| 04 Jan, 2025 | Jane Huang | Common Stock | A | 9,375 | - | 72,716 | D | M |
| 04 Jan, 2025 | Jane Huang | Common Stock | D | 3,859 | $1.39 | 68,857 | D | F |
| 31 Dec, 2024 | Krishna Vaddi | Common Stock | A | 5,000 | $1.21 | 142,553 | I | P |